Skip to main content

Medicare pulls back on coverage of an Alzheimer’s drug

Aduhelm's cost and effectiveness have sparked criticism
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.